Cargando…

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy

The downregulation of WW domain-containing oxidoreductase (WWOX), a tumor suppressor gene, is associated with the tumorigenesis and poor prognosis of various cancers. In this study, we investigated the associations between the polymorphisms of WWOX, clinicopathologic features of prostate cancer (PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chia-Yen, Wang, Chun-Li, Wang, Shian-Shiang, Yang, Cheng-Kuang, Li, Jian-Ri, Chen, Chuan-Shu, Hung, Sheng-Chun, Chiu, Kun-Yuan, Cheng, Chen-Li, Ou, Yen-Chuan, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266044/ https://www.ncbi.nlm.nih.gov/pubmed/37324196 http://dx.doi.org/10.7150/ijms.84364

Ejemplares similares

Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy
por: Chang, Li-Wen, et al.
Publicado: (2023)

Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics
por: Lin, Chia-Yen, et al.
Publicado: (2019)

Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
por: Hu, Ju-Chuan, et al.
Publicado: (2020)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy
por: Hsieh, Hsiang-Chen, et al.
Publicado: (2022)

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
por: Hu, Ju-Chuan, et al.
Publicado: (2021)

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics
por: Hung, Sheng-Chun, et al.
Publicado: (2018)

Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
por: Yang, Cheng-Kuang, et al.
Publicado: (2023)

Real world treatment sequences and outcomes for metastatic renal cell carcinoma
por: Lai, Gu-Shun, et al.
Publicado: (2023)

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
por: Chen, Chuan-Shu, et al.
Publicado: (2020)

Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Wang, Shian-Shiang, et al.
Publicado: (2013)

Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: perioperative, oncologic and functional outcomes
por: Hung, Chi-Feng, et al.
Publicado: (2014)

Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
por: Chang, Li-Wen, et al.
Publicado: (2021)

The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan
por: Chang, Li-Wen, et al.
Publicado: (2023)

Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance
por: Yang, Che Hseuh, et al.
Publicado: (2021)

First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

WWOX Phosphorylation, Signaling, and Role in Neurodegeneration
por: Liu, Chan-Chuan, et al.
Publicado: (2018)

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

Theranostic Robot-Assisted Radical Prostatectomy: Things Understood and Not Understood
por: Hsu, Chao-Yu, et al.
Publicado: (2023)

The surgical learning curve for robotic-assisted laparoscopic radical prostatectomy: experience of a single surgeon with 500 cases in Taiwan, China
por: Ou, Yen-Chuan, et al.
Publicado: (2014)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
por: Tsay, Ming-Dow, et al.
Publicado: (2019)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2022)

Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy
por: Lu, Chin-Heng, et al.
Publicado: (2019)

Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study
por: Li, Jian-Ri, et al.
Publicado: (2022)

Evaluation of (18)F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
por: Zhou, Xing, et al.
Publicado: (2021)

Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia
por: Mei, Cheng-En, et al.
Publicado: (2022)

Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk
por: Cheng, Hsin-Lin, et al.
Publicado: (2016)

WWOX Possesses N-Terminal Cell Surface-Exposed Epitopes WWOX(7-21) and WWOX(7-11) for Signaling Cancer Growth Suppression and Prevention In Vivo
por: Wang, Wan-Jen, et al.
Publicado: (2019)

Strategies by which WWOX-deficient metastatic cancer cells utilize to survive via dodging, compromising, and causing damage to WWOX-positive normal microenvironment
por: Chou, Pei-Yi, et al.
Publicado: (2019)

Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study
por: Chen, Wei-Cheng, et al.
Publicado: (2023)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

Impact of prostatic anterior fat pads with lymph node staging in prostate cancer
por: Weng, Wei-Chun, et al.
Publicado: (2018)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy
por: Yu, Chia‐Cheng, et al.
Publicado: (2019)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Therapeutic Zfra4-10 or WWOX7-21 Peptide Induces Complex Formation of WWOX with Selective Protein Targets in Organs that Leads to Cancer Suppression and Spleen Cytotoxic Memory Z Cell Activation In Vivo
por: Su, Wan-Pei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qq3ck4b9t9gbcc39s0jam7cpea